BSE: STAR - Strides Pharma Science Limited

Rentabilidad a seis meses: -27.91%

Calendario de promoción Strides Pharma Science Limited

Horario avanzado gráfico sencillo
Financial Markets by TradingView

Acerca de la empresa

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams.

más detalles
It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Añadir a la lista de comparación
Añadir a la lista de vigilancia
Añadir al portafolio
Añadir aviso de precio

EBITDA 3.77
EV/EBITDA 12.02
ISIN INE939A01011
Industry Pharmaceuticals
P/BV 1.06
P/E 75.66
P/S 1.02
Sector Health Care
Валюта inr
Валюта отчета inr
Выручка 27.07
Див.доход ао 0
Дивиденд ао 1.5
Сайт https://www.strides.com
Цена ао 1324.6
Число акций ао 0.0903 млрд
Cambio de precio por día: +0.4362% (676.3)
Cambio de precio por semana.: -0.738% (684.3)
Cambio de precio por mes: -55.54% (1527.7)
Cambio de precio en 3 meses.: -51.81% (1409.6)
Cambio de precio en seis meses: -27.91% (942.2)
Cambio de precio por año: +5.8% (642)
Cambio de precio en 3 años.: +62.44% (418.15)
Cambio de precio en 5 años.: +75.79% (386.4)
Cambio de precio en 10 años.: 0% (679.25)
Cambio de precio desde principios de año.: -1.6% (690.3)
Todos los parámetros

Subestimación

Nombre Significado Calificación
P/S 1.76 8
P/BV 3.44 5
P/E 0 0
EV/EBITDA 22.91 5
Total: 5.5

Eficiencia

Nombre Significado Calificación
ROA, % -1.13 0
ROE, % -3.26 0
Total: 0.6667

Dividendos

Nombre Significado Calificación
Div yield, % 0.0512 0.13
DSI 0.8571 8.57
Total: 1.79

Deber

Nombre Significado Calificación
Debt/EBITDA 11.07 0
Total: 5.8

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 49.63 6
Rentabilidad Ebitda, % -46.65 0
Rentabilidad EPS, % -289.02 0
Total: 3.2
Más detalles

Supervisor Título profesional Pago año de nacimiento
Mr. Arun Kumar Pillai B.Com. Founder & Executive Chairperson 60M 1961 (64 año)
Mr. Badree Komandur MD & Group CEO 44M 1972 (53 año)
Ms. Manjula Ramamurthy Compliance Officer & Company Secretary N/A
Sormistha Ghosh Group General Counsel, Chief Risk Officer & Chief Sustainability Officer N/A
Mr. C. K. Sundar Executive Vice President of Operations N/A
Mr. Kevin P. Cook Senior Vice President of Strides Pharma Inc. N/A
Mr. P. V. S. Ramaraju Chief Operating Officer N/A
Mr. Aditya Arun Kumar Executive Director of Business Development & Director
Mr. Vikesh Kumar Group CFO & Chief Investor Relations Officer 1985 (40 años)
Ms. Surabhi Loshali Group Chief Human Resource Officer 1980 (45 años)

DIRECCIÓN: India, Bengaluru, Strides House - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.strides.com